Clinical Trials on Subfoveal Choroidal Thickness in Belgium

Total 13 results

Novartis

Completed

Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Subfoveal Choroidal Neovascularization (CNV) | Secondary to Age-related Macular Degeneration (AMD)

Germany, Belgium, Spain, Netherlands, United Kingdom, Hungary, Turkey, Israel, Portugal, Australia
Novosanis NV

Completed

Echographic Measurement of Skin Thickness in Children (PIDIC-1)

Skin Thickness

Belgium
Novosanis NV

Completed

Echographic Measurement of Skin Thickness

Skin Thickness

Belgium
University Hospital, Ghent
Dutch Burnwound Foundation, Netherland

Completed

Glyaderm + Split Thickness Skin Graft Versus Split Thickness Skin Graft Alone in Full Thickness Skin Defects

Full Thickness Skin Defects

Belgium
Novartis

Terminated

Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

Macular Degeneration | Choroidal Neovascularization

United Kingdom, Spain, Netherlands, Hungary, Italy, Denmark, Belgium, Austria, France, Germany, Poland, Switzerland
Pfizer

Terminated

An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD (PERSPECTIVES)

Macular Degeneration | Age Related Macular Degeneration (AMD) | Choroidal Neovascularization (CNV)

Canada, Belgium, United Kingdom, France, Poland, Spain, Turkey, Czech Republic, Italy, Greece, Germany, Austria, Portugal, Denmark, Finland
University Hospital, Ghent

Completed

Bacterial Control in Partial Thickness Burns Using Silver-containing Wound Dressings

Burn Wounds - Partial Thickness (2nd Degree)

Belgium
University Hospital, Ghent
Research Foundation Flanders

Completed

A Single-stage Bilayered Skin Reconstruction With Glyaderm®

Burns | Necrotizing Fascitis | Full Thickness Burn

Belgium
Euro Tissue Bank
Dutch Burns Foundation

Terminated

Glyaderm Clinical Evaluation Multicenter Study

Full-thickness Skin Loss Due to Burn, Unspecified Site

Spain, Netherlands, Belgium, Greece
Novartis Pharmaceuticals

Completed

Randomized Study for Efficacy and Safety of Ranibizumab 0.5mg in Treat-extend and Monthly Regimens in Patients With nAMD (TREND)

Age-related Macular Degeneration | Choroidal Neovascularization

Korea, Republic of, Croatia, Germany, India, Russian Federation, Turkey, United Kingdom, Egypt, Israel, Belgium, Denmark, Hungary, Slovenia, Spain, Switzerland, Italy, Portugal, Slovakia, Chile
Université Catholique de Louvain
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Terminated

TuLip : Role of the Tumor Environment in Cancer-related Fat Loss (TuLip)

Cancer | Cachexia | Adipose Tissue

Belgium
Quark Pharmaceuticals

Completed

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) (MATISSE)

Diabetic Retinopathy | Diabetic Macular Edema | Choroidal Neovascularization

United States, Israel, United Kingdom, Belgium, Germany, Poland, Czech Republic
Dr. Michael Chourdakis
Hacettepe University; Oslo University Hospital; Ludwig-Maximilians - University... and other collaborators

Completed

Effects of Oral Nutrition Supplements in Children With Disease Associated Underweight (MIntS)

Disease Associated Underweight

Belgium, France, Turkey, Greece, Croatia, Iran, Islamic Republic of, Norway, Poland, Russian Federation

Clinical Trials on Subfoveal Choroidal Thickness in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guatemala

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations